A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason ® ) Ultrasound Enhancing Agent.
Serena ArnoukQuy HuynhMuhamed SaricJohn PapadopoulosPublished in: Journal of pharmacy practice (2023)
Ultrasound enhancing agents (UEAs) are medications that enable clear visualization of ultrasound images. While large studies have demonstrated the safety of these agents, case reports of life-threatening reactions temporally associated with their use have been published and reported to the Food and Drug Administration. Current literature describes the most serious adverse reactions due to UEAs to be allergic in nature; however, embolic phenomena may play a role as well. Here, we report a case of unexplained cardiac arrest following the administration of sulfur hexafluoride (Lumason ® ) in an adult inpatient undergoing echocardiography where resuscitative efforts were ultimately unsuccessful, and review possible mechanisms of cardiac arrest based on prior published literature.
Keyphrases
- cardiac arrest
- cardiopulmonary resuscitation
- magnetic resonance imaging
- systematic review
- drug administration
- ultrasound guided
- contrast enhanced ultrasound
- deep learning
- computed tomography
- left ventricular
- mental health
- palliative care
- high dose
- randomized controlled trial
- heart failure
- convolutional neural network
- emergency department
- optical coherence tomography